Laser Treatment Reverses Skin Aging at the DNA Level in Clinical Study
A fractional laser shifted epigenetic markers at 83.9% of aging-linked DNA sites, with visible improvements lasting six months.
Summary
A peer-reviewed study tested a 1940 nm non-ablative fractional laser on 22 adults using a split-face design, treating one side and leaving the other as a control. Researchers analyzed over 3.8 million DNA methylation sites and found that 83.9% of aging-associated sites shifted in a direction consistent with biological age reversal. Visible improvements matched the molecular data — brown spots dropped by a median of 38% at one month. Changes in gene activity related to collagen production, skin barrier function, and epidermal renewal were also detected. Effects emerged at one month, peaked at three months, and held steady through six months, suggesting durable epigenetic remodeling from a single laser treatment course.
Detailed Summary
Skin aging has long been treated at the surface, but a new study suggests a common laser therapy may reach deeper — all the way to the epigenome. Researchers examined whether a 1940 nm non-ablative fractional laser could alter the DNA methylation patterns that govern how skin genes are expressed and how biologically old skin tissue appears at a molecular level.
The split-face trial enrolled 22 adults and treated one side of the face while leaving the other untreated. Over nine months, researchers profiled more than 3.8 million CpG methylation sites per sample. They found that 83.9% of sites strongly associated with skin aging shifted in a direction consistent with biological age reversal. A total of 635 differentially methylated regions emerged just one month post-treatment, expanded through three months, and stabilized at six months — suggesting lasting epigenetic reprogramming rather than a temporary response.
The molecular changes aligned closely with measurable visual improvements. VISIA imaging showed a median 38% reduction in brown spots on the treated side at one month, alongside improvements in skin texture and overall pigmentation. Gene pathways involved in collagen synthesis, skin barrier integrity, and epidermal differentiation were among those modulated.
The study also flagged changes at keratinocyte-regulating gene loci — including FGFR3 and HOXB4 — which have been linked in other research to basal and squamous cell skin cancer biology. Whether laser-induced modulation of these sites is beneficial, neutral, or warrants monitoring remains to be established.
Caveats are significant. The study was conducted in partnership with the device manufacturer, Candela, introducing potential bias. The sample size of 22 is small, there was no long-term follow-up beyond nine months, and independent replication is needed. Still, the epigenetic framing of a widely available aesthetic treatment represents a meaningful scientific step for skin longevity research.
Key Findings
- 83.9% of aging-associated DNA methylation sites shifted toward biological age reversal after laser treatment.
- Brown spot counts on the treated side fell by a median of 38% at one month post-treatment.
- 635 differentially methylated regions appeared at one month, expanding through three months and stabilizing at six months.
- Gene pathways for collagen regeneration, skin barrier integrity, and epidermal differentiation were all modulated.
- Changes at cancer-linked keratinocyte loci (FGFR3, HOXB4) were detected, warranting further safety investigation.
Methodology
This is a news report summarizing a peer-reviewed split-face clinical study published in Scientific Reports, a credible open-access journal. The research was industry-funded and conducted in partnership with Candela, the device manufacturer, which introduces potential commercial bias. Evidence basis is molecular epigenomics combined with quantitative imaging across a small 22-adult cohort.
Study Limitations
The study was funded and co-conducted by the device manufacturer, raising conflict-of-interest concerns that could influence interpretation of results. The sample size of 22 adults is small, and the nine-month follow-up window does not establish long-term durability of epigenetic changes. Independent replication in larger, unsponsored trials is essential before these findings can be considered definitive.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: